期刊文献+

伏立康唑治疗老年恶性血液病侵袭性真菌感染疗效分析 被引量:9

Efficacy of voriconazole in treatment of invasive fungal infections in elderly patients with hematological malignancies
原文传递
导出
摘要 目的探讨伏立康唑在老年恶性血液病侵袭性真菌感染患者中的临床疗效及不良反应。方法对2007年5月-2011年12月的50例老年恶性血液病侵袭性真菌感染患者的临床资料进行回顾性分析。结果确诊4例,临床诊断20例,拟诊26例;14例患者为初始治疗,36例患者为挽救治疗;总有效率为74.0%,确诊组4例均有效,临床诊断组有效率70.0%,拟诊组有效率73.1%;初始治疗有效率85.7%,挽救治疗有效率69.4%;经过静脉注射的患者有效率76.3%,单纯口服治疗有效率66.7%,两组差异无统计学意义;10例患者曲霉菌属感染,6例有效,曲霉菌属清除;粒细胞缺乏影响伏立康唑疗效,粒细胞缺乏组有效率58.4%,低于无粒细胞缺乏组的88.5%(P<0.05);主要不良反应为肝功能异常、视觉障碍、幻觉,停药后可消失,未观察到肾毒性及心脏毒性。结论伏立康唑可安全有效地治疗老年恶性血液病侵袭性真菌感染。 OBJECTIVE To clarify the efficacy of voriconazole for the invasive fungal infections(IFI) in the elderly patients with hematological malignancies and observe the adverse reactions.METHODS The clinical data of 50 elderly IFI patients with hematological malignancies who were treated with voriconazole from May 2007 to Dec 2011 were analyzed retrospectively.RESULTS There were 4 cases confirmed,20 cases clinically diagnosed,and 26 cases suspected;there were 14 cases treated with initial therapy,36 cases with rescue therapy;the total effective rate was 74.0%,4 confirmed cases were proven effective to voriconazole,the effective rate of the clinically diagnosed cases was 70.0%,the suspected diagnosis group 73.1%;the effective rate of the initial therapy was 85.7%,the rescue therapy 69.4%;the effective rate of the patients receiving intravenous injection was 76.3%,the patients treated with simple oral administration 66.7%,the differences were not statistically significant;there were totally 10 patients infected with Aspergillus,6 cases were effective and Aspergillus were eradicated.Agranulocytosis affected the efficacy of voriconazole,the response rate of agranulocytosis group was 58.4%,lower than 88.5% of the non-agranulocytosis group(P0.05);the abnormal liver function,visual impairment,and hallucination were the main adverse reactions,which disappeared as drugs were withdrawn,the renal toxicity and cardiac toxicity were not observed.CONCLUSION Voriconazole is effective and safe,as is applied for the treatment of invasive fungal infections in elderly patients with hematologic malignancies.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第14期3153-3155,共3页 Chinese Journal of Nosocomiology
关键词 伏立康唑 侵袭性真菌感染 恶性血液病 Voriconazole Invasive fungal infection Hematologic malignancies
  • 相关文献

参考文献2

二级参考文献15

  • 1范成太.伏立康唑治疗恶性血液病合并侵袭性真菌感染20例临床分析[J].临床医药实践,2007,16(10):977-979. 被引量:2
  • 2血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:251
  • 3Tong SYC, Peleg AY, Yoog J, etal. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient[J]. Transplant Infect Dis, 2007,9 : 241-243.
  • 4Alfonso D, Isabel M, Mercedes G, et al. Economic evaluation of vorieonazole versus caspofungin for the treatment of invasive as pergillosis in Spain[J]. Clin Drug Invest,2007,27 : 197-205.
  • 5Wingard JR, Herbrecht R, Mauskopf J,et al. Resource use and cost of treatment with vorieonazole or conventional amphotericin B for invasive aspergillosis[J]. Transplant Infect Dis, 2007,9 : 182-188.
  • 6Candoni A, Mestroni R, Darniani D, et al. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies [J].Eur J Haematol, 2005,75 : 227-233.
  • 7Gonzalez-Vicent M, Lassaletta A, Lopez-Pino MA, et al. Aspergillus " fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery[J].Pediatr Trans plant, 2008,12 : 242-245.
  • 8Mukherjee PK, Sheehan DJ, Hitchcock CA. Combination treatment of invasive fungal infections[J]. Clin Microbiol Rev, 2005, 18:163-194.
  • 9Maertens J, Glasmacher A, Herbrecht R, et al. Multicenter, non comparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis[J].Cancer, 2006,107 :2888-2897.
  • 10Marr KA,Boeckh M,Kim HW. Reply to Cesaro and Visintin[J]. Clin Infect Dis, 2005,40 : 1075-1076.

共引文献206

同被引文献72

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部